Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Rao

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Translational Medicine|July 5, 2018
Epstein-Barr virus- and cytomegalovirus-specific immune response in patients with brain cancerZhenjiang Liu, Thomas Poiret, Qingda Meng, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 6, 2017
Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette-Guérin vaccinationDavide Valentini, Martin Rao, Lalit Rane, et al.
Frontiers in Immunology|April 26, 2018
Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell TransplantationThomas Poiret, Rebecca Axelsson-Robertson, Mats Remberger, et al.
Oncotarget|January 8, 2019
Correction: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with gliomaDavide Valentini, Martin Rao, Qingda Meng, et al.
Oncotarget|May 8, 2018
Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with gliomaDavide Valentini, Martin Rao, Qingda Meng, et al.
Oncotarget|June 2, 2018
Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responsesQingda Meng, Davide Valentini, Martin Rao, et al.
Oncotarget|November 9, 2017
Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastomaZhenjiang Liu, Martin Rao, Thomas Poiret, et al.
International Journal of Molecular Sciences|April 26, 2019
Clinically Relevant Immune Responses against Cytomegalovirus: Implications for Precision MedicineJoana R Lérias, Georgia Paraschoudi, Inês Silva, et al.
The Lancet. Infectious Diseases|April 3, 2016
Host-directed therapies for infectious diseases: current status, recent progress, and future prospectsAlimuddin Zumla, Martin Rao, Robert S Wallis, et al.
Ebiomedicine|September 11, 2017
Mesothelin-specific Immune Responses Predict Survival of Patients With Brain MetastasisLiu Zhenjiang, Martin Rao, Xiaohua Luo, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Translational Medicine|July 5, 2018
Epstein-Barr virus- and cytomegalovirus-specific immune response in patients with brain cancerZhenjiang Liu, Thomas Poiret, Qingda Meng, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 6, 2017
Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette-Guérin vaccinationDavide Valentini, Martin Rao, Lalit Rane, et al.
Frontiers in Immunology|April 26, 2018
Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell TransplantationThomas Poiret, Rebecca Axelsson-Robertson, Mats Remberger, et al.
Oncotarget|January 8, 2019
Correction: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with gliomaDavide Valentini, Martin Rao, Qingda Meng, et al.
Oncotarget|May 8, 2018
Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with gliomaDavide Valentini, Martin Rao, Qingda Meng, et al.
Oncotarget|June 2, 2018
Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responsesQingda Meng, Davide Valentini, Martin Rao, et al.
Oncotarget|November 9, 2017
Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastomaZhenjiang Liu, Martin Rao, Thomas Poiret, et al.
International Journal of Molecular Sciences|April 26, 2019
Clinically Relevant Immune Responses against Cytomegalovirus: Implications for Precision MedicineJoana R Lérias, Georgia Paraschoudi, Inês Silva, et al.
The Lancet. Infectious Diseases|April 3, 2016
Host-directed therapies for infectious diseases: current status, recent progress, and future prospectsAlimuddin Zumla, Martin Rao, Robert S Wallis, et al.
Ebiomedicine|September 11, 2017
Mesothelin-specific Immune Responses Predict Survival of Patients With Brain MetastasisLiu Zhenjiang, Martin Rao, Xiaohua Luo, et al.
Pageof 6